James Quigley
Stock Analyst at Goldman Sachs
(4.02)
Main Sectors:
8 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NVS Novartis | Downgrades: Sell | 119 118 | 132.42 | -10.89% | 2 | Sep 12, 2025 | |
KYMR Kymera Therapeutics | Upgrades: Overweight | 49 79 | 57.9 | 36.44% | 6 | Jun 3, 2025 | |
SNY Sanofi | Initiates Coverage On: Neutral | 65 | 50.9 | 27.7% | 1 | Mar 21, 2025 | |
MOR MorphoSys | Downgrades: Equal-Weight | n/a | n/a | n/a | 6 | Jan 19, 2024 | |
GRFS Grifols | Maintains: Neutral | 10 11 | 9.95 | 5.53% | 1 | Dec 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 40 | 37.62 | 6.33% | 10 | Aug 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 12 16 | 4.01 | 299% | 3 | Jun 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 25 | n/a | n/a | 1 | Nov 20, 2017 |